{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:42:36Z","timestamp":1792564956414,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["J 4737-B"],"award-info":[{"award-number":["J 4737-B"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["ABT12-106729\/2022-13"],"award-info":[{"award-number":["ABT12-106729\/2022-13"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ebiom.2025.106091","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:30:38Z","timestamp":1767918638000},"page":"106091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Cross-binding antibodies capable of neutralising diverse hantaviruses are produced in response to Puumala virus infection"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1790-7883","authenticated-orcid":false,"given":"Jordan J.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6266-0512","authenticated-orcid":false,"given":"Stefan","family":"Hatzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill","family":"Vasilev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4506-3756","authenticated-orcid":false,"given":"Robert","family":"Andreata-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy S.","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Mittler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi","family":"Kasikci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4121-776X","authenticated-orcid":false,"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0296718","article-title":"Distribution and prevalence of Sin Nombre hantavirus in rodent species in eastern New Mexico","volume":"19","author":"Banther-McConnell","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012849","article-title":"A human pathogenic hantavirus circulates and is shed in taxonomically diverse rodent reservoirs","volume":"21","author":"Goodfellow","year":"2025","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2025.106091_bib3","author":"Quizon"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106091_bib4","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3390\/v15061313","article-title":"Multiple lineages of Hantaviruses harbored by the Iberian mole (Talpa occidentalis) in Spain","volume":"15","author":"Gu","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/rmv.1722","article-title":"Hantavirus infections in Europe and their impact on public health","volume":"23","author":"Vaheri","year":"2013","journal-title":"Rev Med Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12250-016-3899-x","article-title":"Hantavirus infection: a global zoonotic challenge","volume":"32","author":"Jiang","year":"2017","journal-title":"Virol Sin"},{"key":"10.1016\/j.ebiom.2025.106091_bib7","author":"Hjertqvist"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106091_bib8","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1017\/S0950268810000087","article-title":"Disease burden of Puumala virus infections, 1995\u20132008","volume":"138","author":"Makary","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106091_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1128\/CMR.00062-09","article-title":"A global perspective on hantavirus ecology, epidemiology, and disease","volume":"23","author":"Jonsson","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106091_bib11","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s13280-021-01594-y","article-title":"Climate change accelerates winter transmission of a zoonotic pathogen","volume":"51","author":"Sipari","year":"2022","journal-title":"Ambio"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106091_bib12","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/tbed.12494","article-title":"Spatial and temporal epidemiology of Nephropathia Epidemica Incidence and hantavirus seroprevalence in rodent hosts: identification of the main environmental factors in Europe","volume":"64","author":"Monchatre-Leroy","year":"2017","journal-title":"Transbound Emerg Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106091_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/vbz.2005.5.315","article-title":"Habitat factors associated with bank voles (Clethrionomys glareolus) and concomitant hantavirus in Northern Sweden","volume":"5","author":"Olsson","year":"2005","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1476-072X-6-55","article-title":"Environmental conditions and Puumala virus transmission in Belgium","volume":"6","author":"Linard","year":"2007","journal-title":"Int J Health Geogr"},{"key":"10.1016\/j.ebiom.2025.106091_bib15","article-title":"The impact of wildlife and environmental factors on hantavirus infection in the host and its translation into human risk","volume":"290","author":"Wang","year":"2023","journal-title":"Proc Biol Sci"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106091_bib16","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1093\/ndt\/gfq118","article-title":"Characterization and outcome following Puumala virus infection: a retrospective analysis of 75 cases","volume":"25","author":"Braun","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106091_bib17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/clinids\/11.6.921","article-title":"Clinical characteristics of Nephropathia Epidemica in Sweden: prospective study of 74 cases","volume":"11","author":"Settergren","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106091_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.antiviral.2013.10.001","article-title":"The pathogenesis of nephropathia epidemica: new knowledge and unanswered questions","volume":"100","author":"Mustonen","year":"2013","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/00365549409008583","article-title":"Nephropathia Epidemica in Finland: a Retrospective Study of 126 cases","volume":"26","author":"Mustonen","year":"1994","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106091_bib20","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3201\/eid2905.221625","article-title":"Poor prognosis for puumala virus infections predicted by Lymphopenia and dyspnea","volume":"29","author":"Hatzl","year":"2023","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106091_bib21","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/v11040340","article-title":"Hypopituitarism after Orthohantavirus infection: what is currently known?","volume":"11","author":"Bhoelan","year":"2019","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/v14010045","article-title":"Severity biomarkers in Puumala Hantavirus infection","volume":"14","author":"Outinen","year":"2022","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106091_bib23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3390\/v15030805","article-title":"Puumala Hantavirus infections show extensive variation in clinical outcome","volume":"15","author":"Vaheri","year":"2023","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106091_bib24","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3390\/v6041801","article-title":"Hantavirus Gn and Gc envelope glycoproteins: key structural units for virus cell entry and virus assembly","volume":"6","author":"Cifuentes-Mu\u00f1oz","year":"2014","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106091_bib25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2020.08.023","article-title":"The hantavirus surface Glycoprotein Lattice and its fusion control mechanism","volume":"183","author":"Serris","year":"2020","journal-title":"Cell"},{"issue":"636","key":"10.1016\/j.ebiom.2025.106091_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abl5399","article-title":"Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses","volume":"14","author":"Mittler","year":"2022","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106091_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01600-24","article-title":"Preclinical evaluation of a fully human, quadrivalent-hantavirus polyclonal antibody derived from a non-human source","volume":"15","author":"Brocato","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.ebiom.2025.106091_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.00832","article-title":"Anti-HFRS human IgG produced in transchromosomic bovines has potent hantavirus neutralizing activity and is protective in animal models","volume":"11","author":"Perley","year":"2020","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41541-024-00998-7","article-title":"Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injection","volume":"9","author":"Hooper","year":"2024","journal-title":"Npj Vaccines"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106091_bib30","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/v13040640","article-title":"Genetic Diversity of Puumala orthohantavirus in Rodents and Human Patients in Austria, 2012\u20132019","volume":"13","author":"Camp","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ebiom.2025.106091_bib31","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1111\/1469-0691.12291","article-title":"Hantavirus infections","volume":"21","author":"Av\u0161i\u010d-\u017dupanc","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"24","key":"10.1016\/j.ebiom.2025.106091_bib32","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","article-title":"Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication","volume":"76","author":"Blight","year":"2002","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106091_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1313","article-title":"Generation of plasma cells and CD27\u2212IgD\u2212 B cells during hantavirus infection is associated with distinct pathological findings","volume":"10","author":"Kerkman","year":"2021","journal-title":"Clin Transl Immunol"},{"issue":"23","key":"10.1016\/j.ebiom.2025.106091_bib34","doi-asserted-by":"crossref","first-page":"12781","DOI":"10.1128\/JVI.00794-11","article-title":"Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus","volume":"85","author":"Brown","year":"2011","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106091_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00028-20","article-title":"Neutralizing monoclonal antibodies against the Gn and the Gc of the andes virus Glycoprotein Spike complex protect from virus challenge in a preclinical hamster model","volume":"11","author":"Duehr","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.ebiom.2025.106091_bib36","series-title":"Recombinant Glycoproteins: Methods and Protocols","first-page":"43","article-title":"Production of influenza virus glycoproteins using insect cells","author":"Loganathan","year":"2024"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/cpmc.108","article-title":"An In vitro microneutralization assay for SARS-CoV-2 serology and drug screening","volume":"58","author":"Amanat","year":"2020","journal-title":"Curr Protoc Microbiol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106091_bib38","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/nar\/gkh340","article-title":"MUSCLE: multiple sequence alignment with high accuracy and high throughput","volume":"32","author":"Edgar","year":"2004","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106091_bib39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/sysbio\/syq010","article-title":"New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0","volume":"59","author":"Guindon","year":"2010","journal-title":"Syst Biol"},{"key":"10.1016\/j.ebiom.2025.106091_bib40","doi-asserted-by":"crossref","first-page":"714","DOI":"10.4269\/ajtmh.2000.62.714","article-title":"The incubation period of Hantavirus pulmonary syndrome","volume":"62","author":"Young","year":"2000","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jcv.2008.10.005","article-title":"Nephropathia epidemica with a 6-week incubation period after occupational exposure to Puumala hantavirus","volume":"44","author":"Kramski","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ebiom.2025.106091_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1184362","article-title":"Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature","volume":"14","author":"Cantoni","year":"2023","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106091_bib43","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/infdis\/164.6.1119","article-title":"Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome","volume":"164","author":"Huggins","year":"1991","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.antiviral.2008.09.007","article-title":"Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea","volume":"81","author":"Rusnak","year":"2009","journal-title":"Antiviral Res"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106091_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/135965359900400404","article-title":"Intravenous ribavirin for Hantavirus Pulmonary Syndrome: safety and tolerance during 1 year of open-label experience","volume":"4","author":"Chapman","year":"1999","journal-title":"Antivir Ther"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106091_bib46","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1086\/425007","article-title":"Placebo-Controlled, double-blind trial of intravenous ribavirin for the treatment of Hantavirus cardiopulmonary syndrome in North America","volume":"39","author":"Mertz","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106091_bib47","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/23744235.2017.1293841","article-title":"Insufficient efficacy and safety of intravenous ribavirin in treatment of haemorrhagic fever with renal syndrome caused by Puumala virus","volume":"49","author":"Malinin","year":"2017","journal-title":"Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106091_bib48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3851\/IMP2875","article-title":"A non-randomized multicentre trial of human immune plasma for treatment of Hantavirus Cardiopulmonary Syndrome caused by Andes virus","volume":"20","author":"Vial","year":"2015","journal-title":"Antivir Ther"},{"issue":"468","key":"10.1016\/j.ebiom.2025.106091_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat6420","article-title":"Two recombinant human monoclonal antibodies that protect against lethal Andes hantavirus infection in vivo","volume":"10","author":"Garrido","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2025.106091_bib50","author":"Williamson"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106091_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109086","article-title":"Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection","volume":"35","author":"Engdahl","year":"2021","journal-title":"Cell Rep"},{"issue":"79","key":"10.1016\/j.ebiom.2025.106091_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ade2798","article-title":"Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination","volume":"8","author":"Irrgang","year":"2023","journal-title":"Sci Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106091_bib53","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/all.12966","article-title":"High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers","volume":"72","author":"Boonpiyathad","year":"2017","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106091_bib54","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4049\/jimmunol.130.2.722","article-title":"Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response","volume":"130","author":"Aalberse","year":"1983","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106091_bib55","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2019.04.036","article-title":"Longitudinal analysis of the Human B cell response to Ebola virus infection","volume":"177","author":"Davis","year":"2019","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106091_bib56","doi-asserted-by":"crossref","first-page":"17113","DOI":"10.1038\/nmicrobiol.2017.113","article-title":"Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys","volume":"2","author":"Zeng","year":"2017","journal-title":"Nat Microbiol"},{"issue":"15","key":"10.1016\/j.ebiom.2025.106091_bib57","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1056\/NEJMoa1511410","article-title":"Ebola RNA persistence in semen of Ebola virus disease survivors \u2014 final report","volume":"377","author":"Deen","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib58","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/S2214-109X(16)30243-1","article-title":"Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study","volume":"5","author":"Sissoko","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"25","key":"10.1016\/j.ebiom.2025.106091_bib59","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1500306","article-title":"Persistence of Ebola virus in ocular fluid during convalescence","volume":"372","author":"Varkey","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106091_bib60","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/cid\/ciw601","article-title":"Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days","volume":"63","author":"Diallo","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106091_bib61","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/cea.13107","article-title":"Repeated vaccination with tetanus toxoid of plasma donors with pre-existing specific IgE transiently elevates tetanus-specific IgE but does not induce allergic symptoms","volume":"48","author":"Unger","year":"2018","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib62","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/infdis\/169.1.83","article-title":"Epitope-Specific distribution of IgG subclasses against antigenic domains on glycoproteins of human cytomegalovirus","volume":"169","author":"Urban","year":"1994","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106091_bib63","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/jcm.31.2.368-372.1993","article-title":"Immunoglobulin G subclass responses against the structural components of Puumala virus","volume":"31","author":"Lundkvist","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ebiom.2025.106091_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2025.106091_bib65","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41577-023-00871-z","article-title":"The unique properties of IgG4 and its roles in health and disease","volume":"23","author":"Rispens","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2025.106091_bib66","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0166-0934(92)90132-W","article-title":"Antibodies to Puumala virus in humans determined by neutralization test","volume":"39","author":"H\u00f6rling","year":"1992","journal-title":"J Virol Methods"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106091_bib67","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.immuni.2024.01.017","article-title":"SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase","volume":"57","author":"Srivastava","year":"2024","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib68","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12979-023-00362-8","article-title":"Interseason waning of vaccine-induced hemagglutination inhibition antibody titers and contributing factors to pre-existing humoral immunity against influenza in community-dwelling older adults 75 years and older","volume":"20","author":"Wunderlich","year":"2023","journal-title":"Immun Ageing"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106091_bib69","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/infdis\/jiv313","article-title":"Persistence of antibodies to influenza hemagglutinin and neuraminidase following one or two years of influenza vaccination","volume":"212","author":"Petrie","year":"2015","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106091_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000779","article-title":"Highly differentiated, resting Gn-Specific memory CD8+ T cells persist years after infection by Andes hantavirus","volume":"6","author":"Manigold","year":"2010","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1084\/jem.20100762","article-title":"Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus","volume":"208","author":"Bj\u00f6rkstr\u00f6m","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2025.106091_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.603228","article-title":"Cytokine profiles and antibody response associated to Choclo Orthohantavirus infection","volume":"12","author":"Salinas","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106091_bib73","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3201\/eid0602.000213","article-title":"Sin nombre virus (SNV) Ig isotype antibody response during acute and convalescent phases of Hantavirus pulmonary syndrome","volume":"6","author":"Bostik","year":"2000","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib74","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3201\/eid1201.050930","article-title":"Neutralizing antibodies in survivors of sin Nombre and Andes hantavirus infection","volume":"12","author":"Valdivieso","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106091_bib75","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3201\/eid1003.020821","article-title":"Neutralizing antibodies and sin Nombre virus RNA after recovery from Hantavirus Cardiopulmonary Syndrome","volume":"10","author":"Ye","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ebiom.2025.106091_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103765","article-title":"Delayed viral clearance despite high number of activated T cells during the acute phase in Argentinean patients with Hantavirus pulmonary syndrome","volume":"75","author":"Iglesias","year":"2022","journal-title":"eBioMedicine"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106091_bib77","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.3390\/v15112266","article-title":"Presence and persistence of Andes virus RNA in human semen","volume":"15","author":"Z\u00fcst","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib78","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2172-12-65","article-title":"Cytokine expression during early and late phase of acute Puumala hantavirus infection","volume":"12","author":"Sadeghi","year":"2011","journal-title":"BMC Immunol"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106091_bib79","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/infdis\/jiz005","article-title":"Serum markers associated with severity and outcome of Hantavirus Pulmonary Syndrome","volume":"219","author":"Maleki","year":"2019","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106091_bib80","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/JVI.76.1.444-449.2002","article-title":"Wild-Type puumala hantavirus infection induces cytokines, C-Reactive protein, creatinine, and nitric oxide in cynomolgus macaques","volume":"76","author":"Klingstr\u00f6m","year":"2002","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106091_bib81","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/imm.13322","article-title":"Immune response during hantavirus diseases: implications for immunotherapies and vaccine design","volume":"163","author":"Saavedra","year":"2021","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106091_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004788","article-title":"Hantaan virus infection induces both Th1 and ThGranzyme B+ cell immune responses that associated with viral control and clinical outcome in humans","volume":"11","author":"Ma","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2025.106091_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2021.101495","article-title":"T helper type (Th1\/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: from cytokines produced to immune responses","volume":"70","author":"Aleebrahim-Dehkordi","year":"2022","journal-title":"Transpl Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106091_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012390","article-title":"Innate lymphoid cells are activated in HFRS, and their function can be modulated by hantavirus-induced type I interferons","volume":"20","author":"Garc\u00eda","year":"2024","journal-title":"PLoS Pathog"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425005419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425005419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:39:46Z","timestamp":1778873986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425005419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":83,"alternative-id":["S2352396425005419"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106091","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-binding antibodies capable of neutralising diverse hantaviruses are produced in response to Puumala virus infection","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106091"}}